This week we talk all about the next Reserve Bank of Australia meeting on interest rates. Scheduled for 20 May, many experts predict a cut, but how big are we expecting? Could it be bigger than anyone’s yet anticipated? We ask our experts.
Find out the major money news of the day and how it affects you with Peter Switzer and Paul Rickard.
On this week's show: Burman Invest's Julia Lee, Fairmont Equities' Michael Gable, ELMO's Danny Lessem, Morgans' Raymond Chan and Switzer's Paul Rickard.
Dr Ross explains herd immunity and how it could work in the case of COVID-19.
Catch up with Peter Switzer and Paul Rickard for the latest money news locally and overseas.
Fortescue CEO Elizabeth Gaines joins this week's show, along with Burman Invest's Julia Lee, Shawn and Partners' Adam Dawes and Switzer's Paul Rickard.
Dr Ross Walker shares his criticisms about how the coronavirus pandemic has been handled.
Peter Switzer and Paul Rickard discuss masking up for the economy, rising gold prices and the looming reporting season.
On this week's show: Burman Invest's Julia Lee, Medallion's Michael Wayne, Morgans' Michael Knox and Switzer's Paul Rickard.
Dr Ross Walker examines the effectiveness of hydroxychloroquine.
Peter Switzer and Paul Rickard discuss gains in the stock market despite infection rates in Victoria and the US, the Aussie dollar moving above 71 US cents and when employees will head back to the office.
Joining Peter Switzer on this week's show: Burman Invest's Julia Lee, Shaw and Partners' Adam Dawes, FNArena's Rudi Filapek-Vandyck and Metrics Credit Partners' Andrew Lockhart.
With over 100 vaccines for COVID-19 currently being trialled, Dr Ross Walker explains what vaccination is and how the latest research into Coronavirus vaccines is progressing.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox